Literature DB >> 11619509

Impure science: AIDS, activism, and the politics of knowledge.

S Epstein.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 11619509

Source DB:  PubMed          Journal:  Med Soc (Berkeley)


× No keyword cloud information.
  139 in total

Review 1.  The Golem: uncertainty and communicating science.

Authors:  T Pinch
Journal:  Sci Eng Ethics       Date:  2000-10       Impact factor: 3.525

Review 2.  Technology and effect: HIV/AIDS testing in Brazil.

Authors:  J Biehl; D Coutinho; A L Outeiro
Journal:  Cult Med Psychiatry       Date:  2001-03

3.  Latinos' community involvement in HIV/AIDS: organizational and individual perspectives on volunteering.

Authors:  Jesus Ramirez-Valles; Amanda Uris Brown
Journal:  AIDS Educ Prev       Date:  2003-02

4.  Health care reform and social movements in the United States.

Authors:  Beatrix Hoffman
Journal:  Am J Public Health       Date:  2003-01       Impact factor: 9.308

5.  Confronting the challenges in reconnecting urban planning and public health.

Authors:  Jason Corburn
Journal:  Am J Public Health       Date:  2004-04       Impact factor: 9.308

6.  Research ethics in the era of personalized medicine: updating science's contract with society.

Authors:  Eric M Meslin; Mildred K Cho
Journal:  Public Health Genomics       Date:  2010-08-31       Impact factor: 2.000

7.  Martin Arrowsmith's clinical trial: scientific precision and heroic medicine.

Authors:  Ilana Löwy
Journal:  J R Soc Med       Date:  2010-11       Impact factor: 5.344

8.  Exploring the positions of German and Israeli patient organizations in the bioethical context of end-of-life policies.

Authors:  Aviad Raz; Isabella Jordan; Silke Schicktanz
Journal:  Health Care Anal       Date:  2014-06

9.  Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Sci Technol Human Values       Date:  2015-03-01

Review 10.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.